Useful bacteria

BioGaia

BioGaia develops, markets and sells probiotic products. Probiotics are useful bacteria that have documented positive health effects in the body. The applications for BioGaia products are mainly in gastrointestinal, oral and immune health and the products are available in a variety of different types of bottles. Sales are mainly through distribution partners in pharmacies worldwide. The company has two business areas: Pediatrics and Adult Health.

Financials

BIOGAIA

SEKm 2018 2019 2020
Sales 706 801 1023
Sales growth (%) 14,8 13,4 27,8
EBITDA 267 285 N/A
EBITDA margin (%) 39,1 37,9 35,5
EBIT adj 234 261 277
EBIT adj margin (%) 38 36,9 34,6
Pretax profit 261 277 351
EPS rep 11,75 12,47 15,78
EPS growth (%) 12,1 6,1 26,6
EPS adj 11,75 12,47 15,78
DPS 9 9,5 10
EV/EBITDA (x) 21,5 20,1 15,7
EV/EBIT adj (x) 22 20,6 16,1
P/E (x) 29,8 28,1 22,2
P/E adj (x) 29,8 28,1 22,2
EV/sales (x) 8,1 7,1 5,5
FCF yield (%) 2,7 3,1 3,8
Dividend yield (%) 2,6 2,7 2,9
Net IB debt/EBITDA -1,2 -1,2 -1,2

Main shareholders

BioGaia

Main shareholders Share capital % Voting shares % Verified
Peter Rotschild & Jan Annwall 6.3 % 32.4 % 31 Dec 2018
Swedbank Robur Fonder 9.4 % 6.8 % 31 Dec 2018
Fjärde AP-fonden 8.1 % 5.9 % 31 Dec 2018
Sebastian Jahreskog 6.9 % 5.0 % 28 Oct 2016
David Dangoor 3.0 % 2.2 % 31 Dec 2018
Juno Investment Partners 2.4 % 1.7 % 30 Sep 2018
Allianz Global Investors 1.6 % 1.2 % 30 Nov 2018
Didrik Hamilton 1.4 % 1.0 % 31 Dec 2018
Dimensional Fund Advisors 1.4 % 1.0 % 30 Nov 2018
Tredje AP-fonden 1.4 % 1.0 % 31 Dec 2018
Source: Holdings by Modular Finance AB

Insider list

BioGaia

Name
Isabelle Ducellier
Per Aniansson
Annwall & Rothschild Investments AB
Annwall & Rothschild Investments AB
Peter Michael Rothschild
Isabelle Ducellier
Annwall & Rothschild Investments AB
Åsa Skansjö Sjöblad
Welin-Berger, Katayoun
Welin-Berger, Katayoun
Show More